Market Research Logo

Global Chronic Obstructive Pulmonary Disease Epidemiology and Patient Flow Analysis - 2017

Global Chronic Obstructive Pulmonary Disease Epidemiology and Patient Flow Analysis - 2017

Fore Pharma announced the results of its Chronic Obstructive Pulmonary Disease patients study in a new report ‘Global Chronic Obstructive Pulmonary Disease Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Chronic Obstructive Pulmonary Disease epidemiology, Chronic Obstructive Pulmonary Disease diagnosed patients, and Chronic Obstructive Pulmonary Disease treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Chronic Obstructive Pulmonary Disease derived from epidemiological analysis, percentage of patients diagnosed with Chronic Obstructive Pulmonary Disease, and percentage of patients treated with a therapy.

The study helps executives estimate Chronic Obstructive Pulmonary Disease market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Chronic Obstructive Pulmonary Disease prevalence, Chronic Obstructive Pulmonary Disease diagnosis rate, and Chronic Obstructive Pulmonary Disease treatment rate for the period 2016 - 2025. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.

Key Features of the Report:

  • Chronic Obstructive Pulmonary Disease Patient Flow
  • Chronic Obstructive Pulmonary Disease Prevalence
  • Chronic Obstructive Pulmonary Disease Diagnosed Patients
  • Chronic Obstructive Pulmonary Disease Treated Patients


1. Chronic Obstructive Pulmonary Disease: Disease Definition
2. Global Chronic Obstructive Pulmonary Disease Patient Flow
2A. Global Chronic Obstructive Pulmonary Disease Prevalence
2B. Global Chronic Obstructive Pulmonary Disease Diagnosed Patients
2C. Global Chronic Obstructive Pulmonary Disease Treated Patients
3. Chronic Obstructive Pulmonary Disease Patient Flow in the US
3A. Chronic Obstructive Pulmonary Disease Prevalence in the US
3B. Chronic Obstructive Pulmonary Disease Diagnosed Patients in the US
3C. Chronic Obstructive Pulmonary Disease Treated Patients in the US
4. Chronic Obstructive Pulmonary Disease Patient Flow in Europe
4A. Chronic Obstructive Pulmonary Disease Prevalence in Europe
4B. Chronic Obstructive Pulmonary Disease Diagnosed Patients in Europe
4C. Chronic Obstructive Pulmonary Disease Treated Patients in Europe
5. Chronic Obstructive Pulmonary Disease Patient Flow in Germany
5A. Chronic Obstructive Pulmonary Disease Prevalence in Germany
5B. Chronic Obstructive Pulmonary Disease Diagnosed Patients in Germany
5C. Chronic Obstructive Pulmonary Disease Treated Patients in Germany
6. Chronic Obstructive Pulmonary Disease Patient Flow in France
6A. Chronic Obstructive Pulmonary Disease Prevalence in France
6B. Chronic Obstructive Pulmonary Disease Diagnosed Patients in France
6C. Chronic Obstructive Pulmonary Disease Treated Patients in France
7. Chronic Obstructive Pulmonary Disease Patient Flow in Spain
7A. Chronic Obstructive Pulmonary Disease Prevalence in Spain
7B. Chronic Obstructive Pulmonary Disease Diagnosed Patients in Spain
7C. Chronic Obstructive Pulmonary Disease Treated Patients in Spain
8. Chronic Obstructive Pulmonary Disease Patient Flow in Italy
8A. Chronic Obstructive Pulmonary Disease Prevalence in Italy
8B. Chronic Obstructive Pulmonary Disease Diagnosed Patients in Italy
8C. Chronic Obstructive Pulmonary Disease Treated Patients in Italy
9. Chronic Obstructive Pulmonary Disease Patient Flow in UK
9A. Chronic Obstructive Pulmonary Disease Prevalence in UK
9B. Chronic Obstructive Pulmonary Disease Diagnosed Patients in UK
9C. Chronic Obstructive Pulmonary Disease Treated Patients in UK
10. Chronic Obstructive Pulmonary Disease Patient Flow in Japan
10A. Chronic Obstructive Pulmonary Disease Prevalence in Japan
10B. Chronic Obstructive Pulmonary Disease Diagnosed Patients in Japan
10C. Chronic Obstructive Pulmonary Disease Treated Patients in Japan
11. Research Methodology
List of Tables
Table 1: Global Chronic Obstructive Pulmonary Disease Patient Flow, 2016
Table 2: Global Chronic Obstructive Pulmonary Disease Patient Flow Forecast, 2016 - 2025
Table 3: Chronic Obstructive Pulmonary Disease Patient Flow in the US, 2016
Table 4: Chronic Obstructive Pulmonary Disease Patient Flow Forecast in the US, 2016 - 2025
Table 5: Chronic Obstructive Pulmonary Disease Patient Flow in Europe, 2016
Table 6: Chronic Obstructive Pulmonary Disease Patient Flow Forecast in Europe, 2016 - 2025
Table 7: Chronic Obstructive Pulmonary Disease Patient Flow in Germany, 2016
Table 8: Chronic Obstructive Pulmonary Disease Patient Flow Forecast in Germany, 2016 - 2025
Table 9: Chronic Obstructive Pulmonary Disease Patient Flow in France, 2016
Table 10: Chronic Obstructive Pulmonary Disease Patient Flow Forecast in France, 2016 - 2025
Table 11: Chronic Obstructive Pulmonary Disease Patient Flow in Spain, 2016
Table 12: Chronic Obstructive Pulmonary Disease Patient Flow Forecast in Spain, 2016 - 2025
Table 13: Chronic Obstructive Pulmonary Disease Patient Flow in Italy, 2016
Table 14: Chronic Obstructive Pulmonary Disease Patient Flow Forecast in Italy, 2016 - 2025
Table 15: Chronic Obstructive Pulmonary Disease Patient Flow in UK, 2016
Table 16: Chronic Obstructive Pulmonary Disease Patient Flow Forecast in UK, 2016 - 2025
Table 17: Chronic Obstructive Pulmonary Disease Patient Flow in Japan, 2016
Table 18: Chronic Obstructive Pulmonary Disease Patient Flow Forecast in Japan, 2016 - 2025
List of Figures
Figure 1: Global Chronic Obstructive Pulmonary Disease Patient Flow, 2016
Figure 2: Global Chronic Obstructive Pulmonary Disease Patient Flow Forecast, 2016 - 2025
Figure 3: Chronic Obstructive Pulmonary Disease Patient Flow in the US, 2016
Figure 4: Chronic Obstructive Pulmonary Disease Patient Flow Forecast in the US, 2016 - 2025
Figure 5: Chronic Obstructive Pulmonary Disease Patient Flow in Europe, 2016
Figure 6: Chronic Obstructive Pulmonary Disease Patient Flow Forecast in Europe, 2016 - 2025
Figure 7: Chronic Obstructive Pulmonary Disease Patient Flow in Germany, 2016
Figure 8: Chronic Obstructive Pulmonary Disease Patient Flow Forecast in Germany, 2016 - 2025
Figure 9: Chronic Obstructive Pulmonary Disease Patient Flow in France, 2016
Figure 10: Chronic Obstructive Pulmonary Disease Patient Flow Forecast in France, 2016 - 2025
Figure 11: Chronic Obstructive Pulmonary Disease Patient Flow in Spain, 2016
Figure 12: Chronic Obstructive Pulmonary Disease Patient Flow Forecast in Spain, 2016 - 2025
Figure 13: Chronic Obstructive Pulmonary Disease Patient Flow in Italy, 2016
Figure 14: Chronic Obstructive Pulmonary Disease Patient Flow Forecast in Italy, 2016 - 2025
Figure 15: Chronic Obstructive Pulmonary Disease Patient Flow in UK, 2016
Figure 16: Chronic Obstructive Pulmonary Disease Patient Flow Forecast in UK, 2016 - 2025
Figure 17: Chronic Obstructive Pulmonary Disease Patient Flow in Japan, 2016
Figure 18: Chronic Obstructive Pulmonary Disease Patient Flow Forecast in Japan, 2016 - 2025

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report